Annie's Apothecary
Annie's Copper (GHK-Cu) Face Cream
Annie's Copper (GHK-Cu) Face Cream
Couldn't load pickup availability
The next generation of skincare is about more than hero ingredients — it is about how those ingredients work together to provide results that deliver a visible difference.
Annie’s Copper (GHK-Cu) Face Cream is at the forefront of this trend. This topical cream integrates high-performance exosomal signaling with precision peptide delivery and synergistic copper-zinc cofactors. By leveraging biomimetic communication and multi-pathway activation, it supports skin conditioning and reinforces natural surface function.
KEY BENEFITS & FEATURES
- Supports overall skin conditioning and visible skin renewal
- Improves the appearance of fine lines, wrinkles and skin texture
- Provides multi-functional skin support through a coordinated peptide system
- Enhances hydration and supports a balanced skin environment
- Designed to maintain peptide stability and support consistent performance
Multi-Functional Peptide Biotechnology
Annie’s Copper (GHK-Cu) Face Cream is designed around complementary peptide and mineral interactions that create a unified renewal cascade:
- GHK-Copper Peptide (Pure) supports the appearance of healthier, smoother and more resilient skin.
- Centella Asiatica-Derived Secretome Peptide Complex stimulates fibroblast communication and anchoring protein production.
- Acetyl Hexapeptide-8 smooths expression lines and relaxes microtensions in facial muscles.
- Zinc Hydrolyzed Hyaluronate offers deep hydration and balances the skin microbiome to support the skin barrier.
Together, these ingredients promote relaxation and hydration to achieve smoother texture and visibly stronger skin integrity.
Technical Reports:- A Clinical Evaluation of the Anti-Wrinkle Effects of PCCA ExoBlueTM. 2026 PCCA Science. 100185.
- Evaluation of the Soothing ENects of E3 Topical Cream (ExoBlueTM) in an SDS-Induced Irritation Model Using Reconstructed Full-Thickness Human Skin. 2026 PCCA Science. 100182.
- Evaluation of the Anti-Senescence Effects of E3 Topical Cream (ExoBlueTM) on Human Dermal Fibroblasts: Hydrolase Enzyme (Part 1). 2026 PCCA Science. 100183.
- Evaluation of the Anti-Senescence Effects of E3 Topical Cream (ExoBlueTM) on Human Dermal Fibroblasts: Protein Markers (Part 2). 2026 PCCA Science. 100184.
- In Vitro Assessment of PCCA ExoBlueTM Using Human Dermal Fibroblasts: Cell Proliferation and Viability. 2026 PCCA Science. 100181.
These statements have not been evaluated by the Food and Drug Administration (FDA). This product is not intended to diagnose, treat, cure, or prevent any disease.
Share
